$Relmada Therapeutics (RLMD.US)$reading about Sepranolone, it's also for women with PMDD. If their time is not now, then maybe one day. I'm so rooting for them to succeed.
$Relmada Therapeutics (RLMD.US)$ Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB Thursday, 6th February at 7:30 am Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement in Tourette symptoms, quality of life and robust overall safety, supporting Sepranolone as a new potential first line treatment option fo...
2
Report
No comment yet
Sign in to post a comment
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Relmada Therapeutics Stock Forum
Relmada Cuts Losses by 25%: Key Pipeline Programs Hit Critical Phase in 2025
Will this be another $Tenon Medical (TNON.US)$
will this be an after hours runner??
Groundbreaking Tourette Treatment Shows 69% QoL Improvement in Clinical Trial - Relmada's Latest Acquisition
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
Thursday, 6th February at 7:30 am
Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB
Phase 2a results signaled improvement in Tourette symptoms, quality of life and robust overall safety, supporting Sepranolone as a new potential first line treatment option fo...
No comment yet